| 药品名称 | MINOCYCLINE HYDROCHLORIDE | | 申请号 | 063009 | 产品号 | 002 | | 活性成分 | MINOCYCLINE HYDROCHLORIDE | 市场状态 | 处方药 | | 剂型或给药途径 | CAPSULE;ORAL | 规格 | EQ 75MG BASE | | 治疗等效代码 | AB | 参比药物 | 否 | | 批准日期 | 2003/08/12 | 申请机构 | ZYDUS WORLDWIDE DMCC
| | 化学类型 | | 审评分类 | |
|
|
| 与本品相关的专利信息（来自橙皮书Orange Book） | | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | | 无 | | 历史专利信息 | | 无 |
|
| 与本品相关的市场独占权保护信息 | | 独占权代码 | 失效日期 | | 无 | | 历史市场独占权保护信息 | | 无 |
|
| 与药品注册相关的信息 | | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | | 063009 | 034 | AP | Label | 2014/02/21 | 下载 | | 063009 | 034 | AP | Letter | 2014/02/24 | 下载 |
|
| 药品注册审批历史信息 | | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | | 063009 | 034 | AP | 2013/01/02 | Labeling Revision | | 063009 | 025 | AP | 2003/08/13 | Labeling | | 063009 | 024 | AP | 2003/08/13 | Chemistry New Strength | | 063009 | 023 | AP | 2001/06/07 | Facility Addition | | 063009 | 022 | AP | 2000/12/07 | Facility Addition | | 063009 | 021 | AP | 2000/12/07 | Facility Addition | | 063009 | 020 | AP | 2000/12/07 | Facility Addition | | 063009 | 019 | AP | 2000/10/26 | Facility Addition | | 063009 | 018 | AP | 2000/07/07 | Facility Addition | | 063009 | 017 | AP | 2000/03/15 | Control Supplement | | 063009 | 016 | AP | 2000/03/15 | Supplier Addition | | 063009 | 015 | AP | 1999/09/20 | Facility Addition | | 063009 | 014 | AP | 1999/09/20 | Facility Addition | | 063009 | 013 | AP | 1999/09/20 | Facility Addition | | 063009 | 012 | AP | 1999/09/20 | Facility Addition | | 063009 | 011 | AP | 1997/12/10 | Chemistry | | 063009 | 010 | AP | 1997/06/18 | Chemistry | | 063009 | 009 | AP | 1996/04/29 | Labeling | | 063009 | 008 | AP | 1995/02/16 | Chemistry | | 063009 | 007 | AP | 1994/09/06 | Chemistry | | 063009 | 006 | AP | 1994/03/31 | Labeling | | 063009 | 005 | AP | 1993/10/06 | Labeling | | 063009 | 004 | AP | 1993/06/11 | Chemistry | | 063009 | 003 | AP | 1993/06/11 | Chemistry | | 063009 | 002 | AP | 1993/11/02 | Chemistry | | 063009 | 001 | AP | 1992/04/17 | Chemistry | | 063009 | 000 | AP | 1992/03/02 | Approval |
|